Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
BMRN2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in BIOMARIN PHARMACEUTICAL INC
Yes. Vanguard Portfolio Management holds 8,648,678 shares of BMRN (Biomarin Pharmaceutical), worth $494.9M, as of its Q2 2026 13F filing. It increased the position by 350,203 shares (+4.2%) from Q1 2026. Vanguard Portfolio Management has held BMRN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$494.9M
Current Shares
8.6M
Total Value Change
+$26.1M
Total Shares Change
+350,203
Quarter-by-Quarter History
Other major holders of BMRN: Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, BlackRock Finance, Inc.